March 2020 Archives - Kybora

首页
关于我们
我们的服务
最新发布
联系我们
中文
- English
- 中文

首页
关于我们
我们的服务
最新发布
联系我们
中文
- English
- 中文

Russian Federation Pharma – March 2020 update

8 6 月, 2020

No comments

News

Russian Federation Pharma – March 2020 update

KYBORA is an experienced global advisory firm that main […]

Recent blog post.

The Latest Trends on Biotech Companies with Negative Enterprise Values: Insights and Implications

Posted: 4 周 ago
KYBORA Advises Lupin on the Divestiture of U.S. Commercial Women’s Health Specialty Business to Evofem

Posted: 1 月 ago
KYBORA’s Charitable Work

Posted: 2 月 ago
Join KYBORA At BIO 2024

Posted: 3 月 ago
Foundation Rwanda Update

Posted: 5 月 ago

Tags.

#biopharma Licensing Announcement Bausch Health biopharma biotechnology China Conference Corporate globalhealthcare healthtech Kybora Team LIcensing March 2020 mergersandacquisitions News Priority List Stada license

我们期待听取您关于业务拓展的需求

KYBORA是一家聚焦创新医药和医疗器械领域的全球化顾问公司。她以帮助客户拓展全球业务并取得卓越业绩为使命，为遍布世界各地的客户提供包括全球产权交易、融资、收并购、资源对接及高端战略咨询在内的优质服务。

关于我们.

关于开博锐
核心团队
成功案例
全球驻地

我们的服务.

收并购
产权交易
融资
战略咨询

最新发布.

The Latest Trends on Biotech Companies with Negative Enterprise Values: Insights and Implications

Posted: 4 周 ago
KYBORA Advises Lupin on the Divestiture of U.S. Commercial Women’s Health Specialty Business to Evofem

Posted: 1 月 ago

© KYBORA All Rights Reserved.

Terms of service | Privacy policy

TYPE & ENTER: